Superhaplogroup JT is an example of reduced risk of Parkinson's disease And mitochondrial and mtDNa alterations continue to be promising disease biomarkers.
The connection between superhaplogroup JT and a lower risk of Parkinson's disease, along with the potential of mitochondrial and mtDNA changes as disease indicators, are key points in this passage.